Примери за използване на Years has not been established на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The safety of TMZ in children under the age of 3 years has not been established.
The safety and efficacy of Repatha in children aged less than 12 years has not been established in the indication for homozygous familial hypercholesterolaemia.
The safety and efficacy of POTELIGEO in children andadolescents aged below 18 years has not been established.
The safety and efficacy of Repatha in children aged less than 18 years has not been established in the indication for primary hypercholesterolaemia and mixed dyslipidaemia.
The safety and efficacy of Avamys in children under the age of 6 years has not been established.
The safety and efficacy of Vimizim in patients older than 65 years has not been established, and no alternative treatment regimen can be recommended in these patients.
The safety and efficacy of TRISENOX in children aged up to 17 years has not been established.
The safety and efficacy of Panretin gel in children under 18 years has not been established. No data are available.
The safety for use during pregnancy, in breast-feeding females, orin patients under 18 years has not been established.
The safety and efficacy of MabThera in children below 18 years has not been established. No data are available.
The safety and efficacy of Cerdelga in children andadolescents under the age of 18 years has not been established.
The safety and efficacy of GANFORT in children aged 0 to 18 years has not been established. No data are available.
The safety and efficacy of pentosan polysulfate sodium in children andadolescent below 18 years has not been established.
The efficacy of macimorelin in patients aged over 65 years has not been established.
The safety and efficacy of Viramune prolonged-release tablets in children aged less than 3 years has not been established.
Apealea in children and adolescents aged 0- 17 years has not been established.
Paediatric population and young adults with open epiphyses The safety and efficacy of FORSTEO in children andadolescents less than 18 years has not been established.
The safety and efficacy of Glybera in children and adolescents below 18 years has not been established. No data are available.
The safety and efficacy of Omidria in children below the age of 18 years has not been established.
Safety and effectiveness in paediatric subjects below the age of two years has not been established(see sections 4.8 and 5.1).
The safety and efficacy of cangrelor in children aged less than 18 years has not been established.
The safety and efficacy of Glybera in children and adolescents below 18 years has not been established.
The efficacy of cetuximab in paediatric patients below the age of 18 years has not been established.
The safety and efficacy of Aptivus capsules in children aged 2 to 12 years has not been established.
The safety and efficacy of LUMIGAN in children aged 0 to less than 18 years has not been established.
The safety and efficacy of GANFORT single-dose in children aged less than 18 years has not been established.
The safety and efficacy of Synjardy in children and adolescents aged 0 to 18 years has not been established.
The safety and efficacy of sodium oxybate in children andadolescents aged 0-18 years has not been established.
The safety and efficacy of GANFORT single-dose in children aged less than 18 years has not been established. No data are available.
The safety and efficacy of sodium oxybate in children andadolescents aged 0-18 years has not been established. No data are available.